17R and NSABP B 42 demonstrating that a prolonged course of aromatase inhibitors in postmenopausal breast cancer patients may improve patient outcomes provides an explanation for extending the duration of endocrine therapy in certain breast cancer patient subtypes priligy walmart ASCO s 2020 Advance of the Year Refinement of Surgical Treatment of Cancer highlights how progress drives more progress